Dexacine Interactions
There are 98 drugs known to interact with Dexacine (dexamethasone / neomycin / polymyxin b ophthalmic), along with 2 disease interactions. Of the total drug interactions, 1 is major, 50 are moderate, and 47 are minor.
- View all 98 medications that may interact with Dexacine
- View Dexacine disease interactions (2)
Most frequently checked interactions
View interaction reports for Dexacine (dexamethasone / neomycin / polymyxin b ophthalmic) and the medicines listed below.
- acetaminophen
- Actonel (risedronate)
- allopurinol
- Alprazolam Intensol (alprazolam)
- aspirin
- atenolol
- Benadryl (diphenhydramine)
- Benicar (olmesartan)
- Byetta (exenatide)
- calcium carbonate
- capsaicin topical
- Celexa (citalopram)
- Chlor-Trimeton Nasal Decongestant (pseudoephedrine)
- Clarinex (desloratadine)
- Claritin-D (loratadine / pseudoephedrine)
- codeine
- Coumadin (warfarin)
- Dexodryl (chlorpheniramine / methscopolamine)
- diclofenac
- Diflucan (fluconazole)
- Diprivan (propofol)
- Ditropan (oxybutynin)
- Elavil (amitriptyline)
- Emetrol for Nausea (phosphorated carbohydrate solution)
- Emetrol, Cherry (phosphorated carbohydrate solution)
- enalapril
- Estratest (esterified estrogens / methyltestosterone)
- lisinopril
- Prilosec (omeprazole)
- Zoloft (sertraline)
Dexacine disease interactions
There are 2 disease interactions with Dexacine (dexamethasone / neomycin / polymyxin b ophthalmic) which include:
Report options
QR code containing a link to this page
More about Dexacine (dexamethasone / neomycin / polymyxin b ophthalmic)
- Compare alternatives
- Side effects
- Dosage information
- During pregnancy
- Drug class: ophthalmic steroids with anti-infectives
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.